Attorney General Pam Bondi traveled to a Drug Enforcement Administration lab to meet with chemists who are tasked with ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its ...

Summer begins early in Hollywood, on the first weekend in May and that kick-off can make or break that pivotal 123 day ...

Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...

Former officials are asking lawmakers to investigate role that Trump’s DEA pick played in deadly overseas incidents.

The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said.

Key Takeaways Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech ...

Jammu: The Jammu and Kashmir State Investigation Agency (SIA) has achieved a breakthrough in its probe into a major drug trafficking case involving the recovery of 33 kg of heroin, with the arrest of ...

In a research report published in Psychedelics, Emory University investigators have uncovered the complex motivations driving ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...

DC isn’t the only place where regulatory burden-boosting policy proposals are garnering bipartisan support. The same ...

Investing.com -- AstraZeneca (LON: AZN ) (ST: AZN) shares fell more than 3% Tuesday after the drugmaker missed first-quarter revenue expectations, with underperformance in key cancer and respiratory ...